1. ERS Conference Sudhir Rao

2. Interventional Pulmonary Procedures- What was New? EBUS-TBNA & EUS-FNA- C Dooms (Leuven, Belgium)- No ROSE and perform at least 4 needle aspirations Molecular EGFR mutation testing using Sanger technique on EBUS- TBNA samples is feasible and robust if a cell block is available with at least 40% nucleated tumor cells In patients with clinical stage III NSCLC, the number of mediastinoscopies needed to detect one additional mediastinal nodal disease after a negative endosonography is 5-7 and for stage I-II is >1

3. Sub-typing EBUS-TBNA samples- by morphology alone 40-70% of cytologies are NSLC-NOS but with immunohistochem this decreases to 15-25% p63-vep63+p63++ TTF1 ++ Adeno TTF1+Adeno Squam TTF1 -ve Adeno Indetermin ate Squam

4. EBUS/EUS ESTS [European Society of Thoracic Surgeons] guidelines 2007 EBUS/EUS short axis d> 10mm &/0r FDG avid central tumour hilar node low FDG uptake

5. Endoscopic treatment of Emphysema